Article

invezz.com on 2023-01-24 16:55

J&J’s upbeat guidance brings good news for big pharma

Johnson & Johnson reports weaker-than-expected Q4 revenue but issues strong guidance for the full year. CFO Joseph Wolk discussed on CNBC.

Related news